21MA045N CAR-T: Differential Alternative Splicing in Relapsed and Refractory Diffuse Large B-Cell Lymphoma Patients Receiving CAR-T Therapy
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828